Ohio
Prescription drug spending and prescribing in Ohio, from Medicare Part D and Medicaid, with the life-science companies raising money there and state attorney general health-care antitrust cases. Compare every state.
In 2024, Medicare Part D plans paid $11.3B for prescriptions written in Ohio, the 6th most of 52 states and territories, and 3.3% of its claims were opioids against 3.5% nationally.
- Medicare Part D, 2024: $11.3B
- Medicaid drugs, 2025: $4.8B
- Opioid share of claims: 3.3%
- Life-science raises, 2 years: $232M
How It Prescribes
Medicare Part D, 2024, by the prescriber's state| Share of Part D claims | Ohio | United States | Difference |
|---|---|---|---|
| Opioids | 3.3% | 3.5% | -8% |
| Antibiotics | 4.5% | 4.4% | +1% |
| Antipsychotics | 1.9% | 1.7% | +7% |
Most Distinctive Drugs
Prescribed most out of line with the rest of the country: the drug's share of Ohio's claims against its share nationally| Drug | Against national rate | Claims |
|---|---|---|
| Dofetilide | 2.1× | 28,801 |
| Mometasone/Formoterol | 2.0× | 31,144 |
| Hydroxyzine Pamoate | 1.9× | 127,498 |
| Paliperidone | 1.9× | 31,319 |
| Rivastigmine Tartrate | 1.6× | 23,509 |
| Sodium Chloride/Nahco3/Kcl/Peg | 1.6× | 24,586 |
| Fluvoxamine Maleate | 1.5× | 27,128 |
| Galantamine Hbr | 1.5× | 16,680 |
| Cariprazine Hcl | 1.5× | 47,571 |
| Colestipol Hcl | 1.5× | 32,743 |
Biggest Medicaid Drugs
What Ohio's Medicaid program paid pharmacies, before rebates; see every drugLife-Science Fundraising
68 Form D raises by companies based in Ohio in the last two years; the 10 largest. See all raises- ENABLE INJECTIONS, INC$30M · Other health care · Jan 9, 2026
- EIKONOKLASTES THERAPEUTICS, INC.$16M · Pharma · Jul 29, 2025
- AndHealth LLC$15M · Hospitals and physicians · Aug 20, 2025
- Cleveland Diagnostics, Inc.$14M · Biotech · Oct 20, 2025
- MediView XR, Inc.$14M · Other health care · Jan 3, 2025
- Onconetix, Inc.$13M · Biotech · Oct 7, 2025
- Blend Innovations, Inc.$12M · Other health care · Aug 7, 2026
- Centerline Biomedical, Inc.$11M · Biotech · Apr 25, 2025
- Helm Health Corp$10M · Other health care · Mar 23, 2026
- Riverain Technologies, Inc.$8M · Other health care · Jan 26, 2026
State Attorney General Health-Care Cases
Antitrust cases Ohio joined, newest first; see every case- Plaintiff States and FTC v. CVET TOPCO, L.P. et al.2026 · Pending
- United States and Ohio v. OhioHealth Corp.2026 · Pending
- Connecticut, et al. v. Sandoz, et al., Case No. 20-cv-3539 (E.D. Pa. June 10, 2020), MDL 2724 (E.D. Pa.)2020 · Pending
- FTC et al. v. Vyera Pharmaceuticals, No. 1:20-cv-00706 (S.D.N.Y. Apr. 19, 2020)2020 · Final judgment
- Connecticut et al. v. Teva Pharmaceuticals USA, Inc. et al., No. 2:19-cv-02407, (E.D. Pa. filed in MDL 05/30/2019)2019 · Pending
- Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July 19, 2019)2019 · Settled
- California et al. v. Teikoku Seikayu Co.(Lidoderm), No. 3:18-cv-00675 (N.D. Cal. 01/31/18)2018 · Settled
- State of Wisconsin et al. v. Indivior, No. 16-5073 (E.D. Pa. Sept. 22,2016)2016 · Pending
- Connecticut et al. v. Teva Pharmaceuticals et al. Civ. Action No. (D.Conn. Dec. 15, 2016)2016 · Pending
- New York et al. v. Cephalon, No. 2:16-cv-04234 (E.D. Pa. Aug. 4, 2016)2016 · Settled
Other States
Alabama · Alaska · Arizona · Arkansas · California · Colorado · Connecticut · Delaware · District of Columbia · Florida · Georgia · Hawaii · Idaho · Illinois · Indiana · Iowa · Kansas · Kentucky · Louisiana · Maine · Maryland · Massachusetts · Michigan · Minnesota · Mississippi · Missouri · Montana · Nebraska · Nevada · New Hampshire · New Jersey · New Mexico · New York · North Carolina · North Dakota · Oklahoma · Oregon · Pennsylvania · Puerto Rico · Rhode Island · South Carolina · South Dakota · Tennessee · Texas · Utah · Vermont · Virginia · Washington · West Virginia · Wisconsin · Wyoming
Part D is by the prescriber's state, Medicaid by the paying state program, and Form D by the issuer's stated address. Amounts are before manufacturer rebates. Refreshed weekly. CMS Medicare Part D Prescribers by Geography; CMS State Drug Utilization Data; SEC Form D; NAAG